Phase II Study of Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2017
At a glance
- Drugs Copanlisib (Primary) ; Cisplatin; Gemcitabine
- Indications Biliary cancer; Cholangiocarcinoma; Gallbladder cancer
- Focus Therapeutic Use
- 12 Dec 2017 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 29 Jun 2016 Status changed from not yet recruiting to recruiting.
- 09 Jun 2016 Planned initiation date changed from 1 Jul 2016 to 1 Sep 2016.